NICOLE CICHETTI: Open Payments
NPI 1790355931 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,224 in 27 payments from 9 companies in 2025. Trend: 2023 $200 · 2024 $448 · 2025 $1,224
Food & beverage: $1,224
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $301 |
| Kestra Medical Technology Services, Inc. | 14 | $198 |
| AstraZeneca Pharmaceuticals LP | 2 | $186 |
| Medtronic, Inc. | 2 | $183 |
| Novartis Pharmaceuticals Corporation | 2 | $136 |
| Novo Nordisk Inc | 1 | $110 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $45 |
| ABIOMED | 1 | $42 |
| Hologic Sales and Service, LLC | 1 | $22 |
Products named: AMVUTTRA, Assure WCD, WAINUA, SYMPLICITY G3, LEQVIO, Ozempic, LifeVest, MYOSURE TISSUE REMOVAL DEVICE.
Industry payments across NJ — which companies pay providers there.
